Low-dose pembrolizumab plus chemotherapy improves survival and expands access in advanced NSCLC
Low-dose pembrolizumab plus chemotherapy improves survival and expands access in advanced NSCLC
Distinct lung microbiome patterns identified in Portuguese patients with lung cancer
Education and training in breast cancer care
Microplastics found at higher levels in prostate cancer tissue compared to benign tissue
First real-world study of penile cancer in Bolivia reveals high HPV-related rates and advanced disease
Patients with non-metastatic HSPC prefer ARPI-based therapy over androgen deprivation alone
Neoadjuvant cabozantinib plus nivolumab before cytoreductive nephrectomy shows promising responses in metastatic clear cell RCC
ASCO GU 2026: Updates in bladder cancer
ASCO GU 2026: Updates in metastatic prostate cancer
ASCO GU 2026: Updates in localised prostate cancer
The Vanessa Moss Prize: celebrating research into cancer health disparities
Can public–private partnerships accelerate cancer research and clinical trials in LMICs?